<p>Model: 6- to 8-week-old male C57BL/6J mice</p>
<p>Dosage: 0.5 mg/kg of isolated mitochondria injected every two days for six injections in the tail vein</p>


Mitochondrial Transplantation Rejuvenates Aging Hearts, Study Finds

Transplantation of the cell’s powerhouses (mitochondria) improves heart function by restoring mitophagy (the cellular process that clears damaged mitochondria) in a mouse model of cardiac aging.

(An image depicting mitochondria [ovoid structures] in cardiac tissue | NAD.com)

Mitochondrial transplantation improves heart function by restoring the cellular process that clears damaged mitochondria in a mouse model of cardiac aging.

Cardiovascular

Aging Clocks Applied to Human Trial Data Support AI-Designed Drug Lowering Age

Six proteomics-based aging clocks (age assessments from large-scale analyses of proteins) agreed that patients treated with the AI-designed drug rentosertib appeared younger.

(A vial containing rentosertib tablets | New York Times)

The AI-designed drug rentosertib was shown to lower biological age across six aging clocks in patients with idiopathic pulmonary fibrosis.

Aging &amp; Longevity

Scientists find that meloxicam preserves muscle mass and strength in aged mice while sustaining mitochondrial function and activating multiple molecules associated with longevity. 


Skin &amp; Muscle

Bryan Johnson’s “Clone”: Where the Sci-Fi Ends and the Science Begins

The biohacker says his “newborn” clone could supply young blood, test experimental treatments, and eventually grow replacement organs.

(Bryan Johnson says he’s cloned himself, which could supply young blood, help test experimental treatments, and eventually grow replacement organs. | Futurism)

Finalist Teams Awarded $1 Million in XPrize Healthspan Contest to Transform Healthy Aging

The XPrize Healthspan—which will split $101 million among teams developing therapeutics to restore muscle, cognitive, and immune function in older adults—has named 10 teams receiving $1 million each.

(XPrize announced the finalists for its XPrize Healthspan competition | XPrize)

The XPrize Healthspan competition has named its top 20 finalist groups that will submit their aging intervention therapies for human trial testing.

Search Result: Young blood

Mitochondrial Transplantation Rejuvenates Aging Hearts, Study Finds

Aging Clocks Applied to Human Trial Data Support AI-Designed Drug Making People Younger

Repurposed Arthritis Drug Counters Muscle Mass Loss with Age, New Study Shows

Bryan Johnson’s “Clone”: Where the Sci-Fi Ends and the Science Begins

10 Finalist Teams Awarded $1 Million in XPrize Healthspan Contest to Transform Healthy Aging